KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Interest Expenses (2016 - 2018)

Zimmer Biomet Holdings has reported Interest Expenses over the past 8 years, most recently at $68.3 million for Q3 2018.

  • For Q3 2018, Interest Expenses fell 17.01% year-over-year to $68.3 million; the TTM value through Jun 2019 reached $68.3 million, down 78.46%, while the annual FY2017 figure was $327.5 million, 8.49% down from the prior year.
  • Interest Expenses for Q3 2018 was $68.3 million at Zimmer Biomet Holdings, down from $75.9 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $91.5 million in Q3 2016 and troughed at $11.6 million in Q2 2014.
  • A 5-year average of $66.0 million and a median of $82.3 million in 2017 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: plummeted 36.61% in 2014 and later soared 612.93% in 2015.
  • Year by year, Interest Expenses stood at $16.0 million in 2014, then skyrocketed by 462.5% to $90.0 million in 2015, then increased by 0.11% to $90.1 million in 2016, then fell by 11.21% to $80.0 million in 2017, then fell by 14.62% to $68.3 million in 2018.
  • Business Quant data shows Interest Expenses for ZBH at $68.3 million in Q3 2018, $75.9 million in Q2 2018, and $78.9 million in Q1 2018.